New York, NY, United States of America

Nancy Kemeny


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nancy Kemeny: Innovator in Cancer Treatment

Introduction

Nancy Kemeny is a prominent inventor based in New York, NY (US), known for her significant contributions to cancer treatment. She has developed innovative methods that combine immunotherapy and chemotherapy to enhance patient outcomes. Her work is particularly focused on addressing challenges in treating colorectal cancer and gastric carcinomas.

Latest Patents

Nancy Kemeny holds a patent for a method titled "Method for treating cancer using A33 specific antibodies and chemotherapeutic agents." This invention relates to a combination of immunotherapy and chemotherapy aimed at promoting tumor regression. The method is especially beneficial for patients with tumors that are resistant to one or more chemotherapeutic agents and those with metastasized cancer.

Career Highlights

Throughout her career, Nancy has made significant strides in the field of oncology. Her innovative approaches have garnered attention and respect within the medical community. She continues to work diligently to improve treatment options for cancer patients.

Collaborations

Nancy Kemeny has collaborated with notable professionals in her field, including Sydney Welt and Gerd J Ritter. These partnerships have contributed to the advancement of her research and the development of effective cancer treatment methods.

Conclusion

Nancy Kemeny's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her dedication to improving patient care through her patented methods is commendable and highlights the importance of continued research and development in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…